All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

PHARMACEUTICAL PREPARATION FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY AND DEGENERATIVE DISEASES

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68378041%3A_____%2F25%3A00640306" target="_blank" >RIV/68378041:_____/25:00640306 - isvavai.cz</a>

  • Result on the web

    <a href="https://www.sciencedirect.com/science/article/pii/S1535610825003952" target="_blank" >https://www.sciencedirect.com/science/article/pii/S1535610825003952</a>

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    PHARMACEUTICAL PREPARATION FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY AND DEGENERATIVE DISEASES

  • Original language description

    The invention relates to a pharmaceutical preparation comprising molecular hydrogen H2, with enhanced antioxidant effect, intended for use in the treatment of an inflammatory or degenerative disease of the cornea and/or retina.

  • Czech name

  • Czech description

Classification

  • Type

    P - Patent

  • CEP classification

  • OECD FORD branch

    30207 - Ophthalmology

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2025

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Patent/design ID

    EP3582787

  • Publisher

    EPO_1 -

  • Publisher name

    European Patent Office

  • Place of publication

    Munich, The Hague, Berlin, Vienna, Brussels

  • Publication country

  • Date of acceptance

    Sep 10, 2025

  • Owner name

    Ústav experimentální medicíny AV ČR, v. v. i.

  • Method of use

    B - Výsledek je využíván orgány státní nebo veřejné správy

  • Usage type

    A - K využití výsledku jiným subjektem je vždy nutné nabytí licence